The Mérieux Innovation 2 fund is awarded the Tibi label, in recognition of its support to healthcare innovation in France and Europe, for the benefit of patients.
4 November 2024
Mérieux Equity Partners announces that its Mérieux Innovation 2 (MI2) fund has been awarded the Tibi label.
The MI2 fund’s mission is to accelerate access for patients to products and services with a strong and lasting impact on their health.
